CompletedNCT03423394
Efficacy study of Stress Check-Up
This summary needs review. Please check the official study record and contact the research team for details.
In SeattlePTSDBehavioralOver 18 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
TerminatedNCT06431256
Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD
This study exists to understand whether the medication HLD200 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication HLD200 in practice and what may need to be adjusted.
Multiple locations, including DothanADHDOtherFrom 4 Years to 5 Years
CompletedNCT03965871
Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression in bipolarity
This study exists to compare options and see whether the medication Inhaled offers something meaningfully different. Researchers are trying to understand whether the medication Inhaled can give earlier or clearer feedback during care.
Multiple locations, including BełchatówBipolarity, DepressionOtherFrom 18 Years to 65 Years
CompletedNCT05278156
Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in people with Schizophrenia
This study exists to understand whether the medication CPL500036 is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication CPL500036 can give earlier or clearer feedback during care.
Multiple locations, including BudapestSchizophreniaOtherFrom 18 Years to 65 Years
CompletedNCT00151970
Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD
This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
Location not clearly listedADHDOtherFrom 6 Years to 12 Years
CompletedNCT01567527
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
This study exists to see whether the medication OPC-14597 can make care clearer and more responsive. Researchers are trying to understand whether the medication OPC-14597 can better prevent setbacks and support longer-term stability.
Multiple locations, including BirminghamBipolarityOtherFrom 18 Years to 65 Years
TerminatedNCT03896945
Efficacy, Safety, and Tolerability of AVP-786 for Negative Symptoms of Schizophrenia
This study exists to compare options and see whether the medication AVP-786 offers something meaningfully different. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
Multiple locations, including Little RockSchizophreniaOtherFrom 18 Years to 60 Years
CompletedNCT02477670
Efficacy, Safety, and Tolerability of AVP-786 for Residual Schizophrenia
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including CerritosSchizophreniaOtherFrom 18 Years to 60 Years
Active Not RecruitingNCT05624268
Efficacy, Safety, and Tolerability of COMP360 in people with TRD
This study is active but not recruiting in the United States. It focuses on Depression.
Multiple locations, including TucsonDepressionDrugA study involving a medication or substance.Over 18 Years
CompletedNCT01825837
Efficacy, Safety, and Tolerability of Eslicarbazepine Acetate in the Recurrence Prevention of Bipolarity type I
This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.
Location not clearly listedBipolarityOther
Active Not RecruitingNCT05711940
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in people with TRD
This study is active but not recruiting in the United States, in France, in Canada, .... It focuses on Depression.
Multiple locations, including GilbertDepressionDrugOver 18 Years
CompletedNCT05545111
Safety study of NBI-1117568 in schizophrenia
This study is completed in the United States. It is testing NBI-1117568 for schizophrenia.
Multiple locations, including Little RockSchizophreniaOtherFrom 18 Years to 55 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.